论文信息 - Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma - 字舞流文

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma

Michael L. Wang | Y. Oki | A. Younes | L. Kwak | Lei Feng | L. Fayad | S. Neelapu | M. Fanale | J. Romaguera | F. Samaniego | N. Fowler | A. Copeland | Lei Feng